rFVIIIFc

Related by string. * * Fc fusion protein rFVIIIFc *

Related by context. All words. (Click for frequent words.) 76 rFIXFc 69 lomitapide 67 liposomal formulation 67 refractory gout 67 BAY #-# 67 Bezielle 67 Mipomersen 66 registrational trial 66 PRTX 66 PRT# 66 diabetic neuropathic pain 66 velafermin 66 HuMax EGFr 65 diarrhea predominant irritable 65 JAK inhibitor 65 TELINTRA 65 AEG# 65 relapsing multiple sclerosis 65 Phase #/#a 65 SNT MC# 64 OHR/AVR# 64 Plicera 64 HuMax CD4 64 EndoTAG TM -1 64 Azedra 64 Cetrorelix 64 Fc fusion protein rFVIIIFc 64 recombinant Factor VIII 64 octreotide 64 Arikace 64 orally bioavailable 64 subcutaneously administered 64 MYDICAR ® 64 Traficet EN 64 Ophena TM 64 Sym# 64 leukemia AML 64 IX Fc fusion 64 HQK 64 Xanafide 64 Rezular 64 C1 INH 64 cilengitide 64 sorafenib Nexavar 64 forodesine 64 Tyrima 64 PROCHYMAL 63 Chrysalin 63 Genz # 63 ALN TTR# 63 Dapagliflozin 63 vidofludimus 63 CBLC# 63 lumiliximab 63 RLY# 63 PROMACTA 63 ZOLINZA 63 hyperphenylalaninemia HPA due 63 riociguat 63 vorinostat 63 OncoVEX GM CSF 63 elotuzumab 63 GW# [003] 63 exon skipping 63 INCB# [001] 63 PEG Interferon lambda 63 Golimumab 63 Revimmune 63 docetaxel Taxotere ® 63 CANCIDAS 63 ELACYT 63 synthetic retinoid 63 methylnaltrexone bromide 63 Dasatinib 63 methylnaltrexone 63 Plasmin 63 VAPRISOL 63 mertansine 63 docetaxel chemotherapy 63 formerly LymphoStat B 63 ACZ# 63 invasive candidiasis 63 ximelagatran 63 phase IIb trial 63 lupus nephritis 63 MAGE A3 ASCI 63 Amplimexon 63 injectable formulation 63 TG# [003] 63 oral prodrug 63 azacitidine 63 recombinant factor VIIa 63 Archexin 63 thrombolytic agent 63 pharmacological chaperone 63 Fc fusion protein 62 deferiprone 62 HuLuc# 62 axitinib 62 pegylated liposomal doxorubicin 62 inhibitor RG# 62 standard chemotherapy regimen 62 RECOTHROM R 62 lucinactant 62 sunitinib malate 62 TBC# 62 adult chronic ITP 62 RhuDex ® 62 Onconase 62 nucleoside analog 62 Valdoxan 62 DU #b 62 YONDELIS 62 Amrubicin 62 xanthine oxidase inhibitor 62 vapreotide acetate 62 HGS# 62 TREANDA 62 OncoGel 62 pan HDAC inhibitor 62 relapsed MM 62 lapatinib Tykerb 62 acetonide FA 62 eltrombopag 62 nitazoxanide 62 terlipressin 62 HuMax CD# 62 Factor IX 62 selective androgen receptor modulator 62 corticosteroid dexamethasone 62 CTAP# Capsules 62 canakinumab 62 tocilizumab 62 Aviptadil 62 BAL# [002] 62 Romiplostim 62 Dacogen decitabine 62 subcutaneous formulation 62 investigational monoclonal antibody 62 ProSavin 62 decitabine 62 Aflibercept 62 Amigal 62 MBP# [001] 62 Interferon alpha 62 post herpetic neuralgia PHN 62 Vernakalant 62 TNF Tumor Necrosis Factor 62 TEMODAL 62 ATL# [002] 62 FOLOTYN ® 62 Factor VIIa 62 Microplasmin 62 Pirfenidone 62 Leukine ® 62 tafamidis 62 renin inhibitor 62 Degarelix 62 selective modulator 62 Perforomist ™ Inhalation Solution 62 phase IIa clinical 62 ADP receptor antagonist 62 EOquin TM 62 ALN PCS 62 tyrosine kinase inhibitor 62 polymerase inhibitor 62 Azacitidine 62 Myelodysplastic Syndrome MDS 62 Locteron 62 severe gastroparesis 62 Sudhir Agrawal D.Phil 62 otelixizumab 61 GAMMAGARD 61 Vascugel 61 Alfimeprase 61 CYT# potent vascular disrupting 61 NEUMUNE 61 CA4P 61 ISIS # 61 NV1FGF 61 Pafuramidine 61 Daclizumab 61 Tezampanel 61 HspE7 61 CIMZIA ™ 61 Gabapentin GR 61 Fabry Disease 61 ganetespib 61 Alvesco R 61 Kepivance 61 Eculizumab 61 relapsed multiple myeloma 61 Bicifadine 61 KRN# 61 ketolide antibiotic 61 CIMZIA TM 61 uricase 61 PEG SN# 61 Adalimumab 61 KNS # 61 ularitide 61 reslizumab 61 oxypurinol 61 acute PAO 61 Laquinimod 61 ACTEMRA TM 61 somatostatin analogue 61 investigational compound 61 APOPTONE 61 evaluating tivozanib 61 ARIKACE 61 sorafenib tablets 61 generation purine nucleoside 61 Ganciclovir 61 oxaliplatin Eloxatin 61 ulimorelin 61 romiplostim 61 arsenic trioxide injection 61 Vandetanib 61 phase IIb clinical 61 PNP inhibitor 61 HSP# inhibitor 61 INT# [002] 61 Resten NG 61 rilonacept 61 acting muscarinic antagonist 61 metformin HCl 61 Serdaxin 61 ISTODAX 61 Vidofludimus 61 interferon alfa 61 octreotide acetate 61 registrational 61 IMA# 61 Factor Xa inhibitor 61 Clolar ® 61 tanespimycin 61 Ceflatonin R 61 visilizumab 61 lanreotide 61 bendamustine 61 DDP# 61 Civacir 61 obatoclax 61 antibody MAb 61 Methylnaltrexone 61 Omacetaxine 61 THR beta agonist 61 CIPN 61 Acute Radiation Syndrome ARS 61 marketed pegylated interferons 61 TriRima 61 chronic ITP patients 61 acyclovir Lauriad R 61 Elotuzumab 61 pomalidomide 61 TRO# 61 ALN TTR 61 teduglutide 61 Liprotamase 61 docetaxel Taxotere R 61 Fibrillex TM 61 superficial bladder cancer 61 Cethrin 61 USL# 61 novel topoisomerase 61 PDE4 inhibitor 61 Dalbavancin 61 Kuvan R 61 angiogenesis inhibitor 61 Dacogen injection 61 Elagolix 61 Ophena 61 investigational humanized monoclonal antibody 61 orally dosed 61 nucleotide analog 61 Enzyme Replacement Therapy 61 Hydroxyurea 61 herpetic keratitis 61 refractory angina 61 LB# [003] 61 IRX 2 61 MGd 61 Zerenex 61 Catena ® 61 XmAb# 61 OMNARIS HFA 61 Quinamed 61 ospemifene 61 Increlex ® 61 Alocrest 61 Tamibarotene 61 alfa 2a 61 HCD# [002] 61 Phase IIb clinical trials 60 velaglucerase alfa 60 MTP inhibitor 60 SCH # 60 antiplatelet agent 60 ocrelizumab 60 eniluracil 60 relapsed ovarian cancer 60 miglustat 60 Friedreich Ataxia FRDA 60 Rilonacept 60 Irinotecan 60 VIDAZA 60 basiliximab 60 Certolizumab pegol 60 Pimavanserin 60 R#/MEM # 60 urocortin 2 60 AAG geldanamycin analog 60 Epratuzumab 60 inhaled formulation 60 CD# monoclonal antibody 60 depsipeptide 60 Teriflunomide 60 intravenously administered 60 Cancidas 60 metaglidasen 60 erlotinib Tarceva ® 60 Radilex 60 edoxaban 60 anti CD3 antibody 60 Jevtana 60 Sebivo 60 virus HCV protease inhibitor 60 teriflunomide 60 sitaxsentan 60 opioid induced bowel dysfunction 60 TYSABRI natalizumab 60 baminercept 60 VPRIV 60 CoFactor 60 Octreotide 60 Carfilzomib 60 Fibrin Pad 60 PEGylated Fab fragment 60 huC# DM4 60 Natalizumab 60 Inhalation Solution 60 targeted antifolate 60 ONTAK 60 MEK inhibitor 60 Phenoptin 60 TYZEKA 60 HCV protease inhibitors 60 Anthim 60 Advagraf 60 Icatibant 60 laquinimod 60 Telintra 60 Actemra tocilizumab 60 trabectedin 60 dasatinib Sprycel ® 60 Pegasys ® 60 PXD# 60 ACV1 60 DAPT 60 acute HAE attacks 60 LAF# 60 TRISENOX 60 Nanobody 60 regorafenib 60 Pradefovir 60 Lixivaptan 60 NP2 Enkephalin 60 rHuPH# enzyme 60 CD3 monoclonal antibody 60 placebo controlled clinical 60 novel oral anticoagulant 60 Tarceva TM 60 small molecule thrombopoietin 60 atacicept 60 Zenvia ™ 60 GTC recombinant human 60 Aliskiren 60 AEGR 60 relapsing MS 60 sunitinib 60 Locteron ® 60 delivers fluocinolone acetonide FA 60 eprotirome 60 Rivaroxaban 60 pseudobulbar affect PBA 60 ONCONASE 60 CORT # 60 Alemtuzumab 60 Tasimelteon 60 neurogenic orthostatic hypotension 60 Nexavar ® 60 Maribavir 60 Vaprisol 60 pegfilgrastim 60 Arcalyst 60 Pazopanib 60 Phase Ib clinical 60 targeting CD# 60 CCX# B 60 Triolex 60 TPI ASM8 60 Safinamide 60 AeroLEF TM 60 ApoB SNALP 60 oral formulation 60 oncolytic virus therapy 60 DepoDur 60 VA# [002] 60 SPRYCEL ® 60 Etanercept 60 Ataluren 60 liposome injection 60 PSMA ADC 60 HCV protease inhibitor 60 metastatic malignant 60 AA amyloidosis 60 Indaflex TM 60 pharmacokinetic PK study 60 oral antiviral 60 epothilone 60 Diabetic Macular Edema DME 60 IV Busulfex 60 PKC# 60 MYDICAR 60 REMINYL ® 60 Thiarabine 60 anti amnesic 60 Phase 1b trial 60 multicenter Phase II 60 MNTX 60 anticancer therapies 60 Zirgan 60 adalimumab Humira 60 Aclidinium 60 direct thrombin inhibitors 60 vandetanib 60 Solulin 60 Tanespimycin 60 SARMs 60 Ceflatonin 60 zanolimumab 60 Zorbtive TM 60 tiapamil 60 Vidaza azacitidine 60 Rebif ® 60 AZX# 60 Moxifloxacin 60 ELND# 60 Panzem R NCD 60 omega interferon 60 chronic idiopathic thrombocytopenic purpura 60 somatostatin analog 60 platelet inhibitor 60 dirucotide MBP# 60 PLX cells 60 Lisofylline 60 IAP inhibitor 60 aldosterone antagonists 60 lenalidomide Revlimid R 60 Elesclomol 60 Uricase PEG 60 MKC# MKC# PP 60 CCR9 antagonist 60 rhMBL 60 pegylated interferons 60 Campath alemtuzumab 60 panitumumab Vectibix 60 calcineurin inhibitor 60 MabCampath 60 BYETTA ® 60 Myocet 60 Dabigatran etexilate 60 beta 1a 60 oral anticoagulant 60 Ontak 60 beta2 agonist 60 bexarotene 60 AVONEX ® 60 candidate Zenvia 60 filgrastim 60 BRIM2 60 Nuvion 60 BENLYSTA TM 60 Squalamine 60 vitreoretinal disorders 60 Aggrastat ® tirofiban hydrochloride 60 GSK '# 60 CLORETAZINE TM VNP#M 60 Cleviprex TM clevidipine 60 Panzem R 60 SUTENT ® 60 Symadex 60 etanercept Enbrel 60 photoprotective drug 60 Luteinizing Hormone Releasing Hormone 60 Proxinium TM 60 DPP4 inhibitor 60 posaconazole 60 REVLIMID lenalidomide 60 Cloretazine 60 aerosolized KL4 surfactant 60 AKT inhibitor 60 alvespimycin 60 GFT# 60 phase IIa 60 Meets Primary Endpoint 60 Phase IIb trials 60 pertuzumab 60 humanized anti 60 ACTEMRA 60 pegylated 60 zileuton 60 thalidomide Thalomid 59 LymphoStat B 59 mRCC 59 Fludara 59 LY# [002] 59 Proellex TM 59 evaluating REVLIMID 59 cystinosis patients 59 Cloretazine R VNP#M 59 dirucotide 59 imatinib Gleevec ® 59 Zingo TM 59 ORENCIA R 59 Morquio 59 anti leukemic 59 Neulasta ® 59 relapsing remitting MS RRMS 59 oral salmon calcitonin 59 echinocandin 59 Abbokinase 59 PEGylated anti 59 PD LID 59 diabetic macular edema DME 59 gefitinib Iressa 59 Vilazodone 59 tranilast 59 Belimumab 59 PEGylated 59 Corlux 59 Excellarate TM 59 prucalopride 59 incyclinide 59 Rasagiline 59 Afatinib 59 humanized antibody 59 Ridaforolimus 59 Ozurdex 59 Naproxcinod 59 radiation sensitizer 59 relapsed refractory multiple myeloma 59 immunomodulator 59 Blinatumomab 59 SHPT 59 oral talactoferrin 59 Betaferon R 59 Sanvar R 59 therapeutic monoclonal antibody 59 TLK# 59 NXL# 59 Diabetic Macular Edema 59 antisense drug 59 alkylating agent 59 davunetide 59 daclizumab 59 CEQ# 59 oxymorphone ER 59 targeted radiotherapeutic 59 aclidinium bromide 59 STRIDE PD 59 PREZISTA r 59 Protelos 59 Tofacitinib 59 JAK3 inhibitor 59 SomatoKine 59 angiotensin receptor blocker ARB 59 talactoferrin 59 ambrisentan 59 oral rivaroxaban 59 PGL# 59 Anavex #-# 59 GSK# [002] 59 anticoagulant reversing agent 59 dual endothelin receptor antagonist 59 sodium thiosulfate STS 59 pharmacokinetic interactions 59 cediranib 59 tezampanel 59 refractory acute myeloid 59 BioNumerik 59 PEGylated interferon beta 1a 59 Guanilib 59 either acutely decompensated 59 efalizumab 59 immunomodulatory therapy 59 GRNVAC1 59 ESBA# 59 MAP# 59 LEUKINE 59 Pagoclone 59 cangrelor 59 Hsp# Inhibitor 59 DermaVir Patch 59 alfa interferon 59 eculizumab 59 catheter occlusion 59 SUTENT 59 Preclinical studies suggest 59 infliximab Remicade 59 6R BH4 59 JAK2 inhibitor 59 Durezol 59 Boceprevir 59 Aplidin 59 amrubicin 59 myeloproliferative disorders 59 Aerosurf 59 SPRIX ® 59 antiviral efficacy 59 Fingolimod 59 humanized monoclonal antibody 59 IMiDs 59 Personalized Immunotherapy 59 Abiraterone acetate 59 OZURDEX ® 59 palonosetron 59 oral FTY# 59 Oral NKTR 59 hour bronchodilation 59 amikacin 59 Granulocyte Colony Stimulating Factor 59 Octreolin 59 PHX# 59 Gleevec resistant 59 diabetic gastroparesis 59 MP4OX 59 Fidaxomicin 59 apricitabine 59 tramiprosate 59 placebo controlled Phase 59 injectable formulations 59 Firazyr 59 Lubiprostone 59 RhuDex 59 APTIVUS r 59 Tesetaxel 59 Valsartan 59 TRIOLEX 59 SinuNase TM 59 VELCADE melphalan 59 dexanabinol 59 AZILECT ® 59 prescribed proton pump 59 URG# 59 IMiDs ® 59 TroVax ® 59 Combo Stent 59 sodium glucose cotransporter 59 anticancer agent 59 DCCR 59 Atrasentan 59 noninfectious uveitis 59 immunomodulatory agents 59 PS# [001] 59 RoACTEMRA 59 receptor tyrosine kinase inhibitor 59 metreleptin 59 Noxafil 59 APTIVUS 59 pregabalin Lyrica 59 thetreatment 59 recurrent glioblastoma multiforme 59 By JENNIFER LEARN 59 teplizumab 59 Cethromycin 59 DP b# 59 Desmoteplase 59 rhIGF-I/rhIGFBP-3 59 Liposomal 59 CytoFabTM 59 Revlimid lenalidomide 59 novel VDA molecule 59 IRESSA 59 Wafer polifeprosan 59 Pervasis 59 proteasome inhibitors 59 Bucindolol 59 abiraterone acetate 59 postoperative ileus 59 LY# [003] 59 cetuximab Erbitux R 59 LEXIVA r 59 CCR5 mAb 59 Dupuytren Contracture 59 bevacizumab Avastin ® 59 systemically administered 59 Proquin XR 59 Tavocept 59 Clonicel 59 GRN# 59 Tocilizumab 59 LymphoStat B belimumab 59 trastuzumab DM1 T DM1 59 AZT zidovudine Retrovir 59 Chemophase 59 selective A2A adenosine receptor 59 diabetic macular edema 59 CDP# 59 recurrent genital herpes 59 ON #.Na 59 MoxDuo 59 Viramidine 59 TACI Ig 59 Cx# [002] 59 Dual Opioid 59 NGX# 59 PEGPH# 59 Hepatocellular Carcinoma HCC 59 Annamycin 59 Ostarine 59 NVA# 59 anticancer compound 59 SparVax TM 59 Intervention Effectiveness 59 sapacitabine 59 Torisel 59 elesclomol 59 proteasome inhibitor bortezomib 58 LUX Lung 58 proteasome inhibitor 58 ALGRX 58 sapropterin dihydrochloride 58 ADAGIO study 58 Ruconest 58 CR# vcMMAE 58 drug ISA# 58 aripiprazole Abilify 58 multi kinase inhibitor 58 familial amyloidotic polyneuropathy FAP 58 Ambrisentan 58 dihydrochloride 58 Phase Ib study 58 Etravirine 58 budesonide foam 58 cardio renal 58 Vorinostat 58 peritumoral brain edema 58 Delcath PHP System 58 Aryplase 58 Ramoplanin 58 dextromethorphan quinidine 58 Rituxan rituximab 58 Mg Usa 58 SomatoKine R 58 Nanobody ® 58 Zavesca R 58 Procoralan 58 ostarine 58 Fodosine 58 cathepsin K inhibitor 58 investigational pan BCR 58 colesevelam HCl 58 biologic therapies 58 Campath ® 58 Pyridorin 58 constipation predominant irritable bowel 58 SIR Spheres 58 interferon beta 1b 58 dalbavancin 58 JANUVIA 58 AQ4N 58 rFVIIa 58 Bortezomib 58 clazosentan 58 NovaBay Aganocide compounds 58 volociximab 58 Linaclotide 58 uric acid lowering 58 abacavir lamivudine 58 ThGRF 58 thrombin inhibitor 58 investigational oral 58 modified glutathione analog 58 GED aPC 58 BIO SET 58 idiopathic thrombocytopenic purpura ITP 58 Nexavar sorafenib 58 Phase III Pivotal 58 thymalfasin 58 intravitreal insert 58 FOLOTYN 58 MyVax R 58 Phase 2b study 58 metastatic renal cell carcinoma 58 QLT# 58 stated Michelle Berrey 58 Pivotal Phase III 58 immune modulatory 58 NLX P# 58 torezolid phosphate 58 Voreloxin 58 lubiprostone 58 Adlea 58 HGS ETR1 mapatumumab 58 nucleotide analogs 58 Fleximer 58 eosinophilic asthma 58 Cyclosporine 58 INVANZ 58 Cimzia TM 58 Perifosine 58 alpha 2a 58 Diamyd ® 58 Aptivus ® 58 solithromycin 58 ACAPODENE 58 idraparinux 58 AGILECT R 58 ENMD # 58 Aloxi R 58 fluvastatin 58 ARG# 58 cannabinor 58 IMiDs ® compound 58 paclitaxel poliglumex 58 Phase IIB 58 plasma kallikrein inhibitor 58 chemotherapy induced neutropenia 58 Exelixis compounds 58 Kamada AAT 58 Talabostat 58 masitinib 58 rALLy clinical trial 58 Triapine 58 calcitonin 58 Bioral ® 58 constipation OIC 58 investigational drug 58 NexACT ® 58 personalized immunotherapy 58 RG# [001] 58 novel prodrug 58 R#/MEM 58 MAXY VII 58 rHuPH# 58 bortezomib Velcade 58 Asentar 58 Tibotec Therapeutics division 58 trodusquemine 58 Cloretazine ® 58 Liprostin 58 peginterferon alfa 2a 58 TYKERB 58 direct thrombin inhibitor 58 phase Ib 58 favorable pharmacokinetic profile 58 Cethrin R 58 phase IIb study 58 Syntonix 58 ALN VSP 58 Insegia 58 CytoSorb TM 58 topiramate Topamax 58 Belerofon 58 ankylosing spondylitis psoriatic arthritis 58 Romidepsin 58 docetaxel Taxotere 58 RAPAFLO 58 bevacizumab Avastin 58 Saxagliptin 58 Adentri 58 PROVENGE sipuleucel T 58 oral ridaforolimus 58 histamine dihydrochloride 58 albinterferon alfa 2b 58 anticancer therapy 58 Solesta 58 Xyfid TM 58 Corgentin 58 liposomal 58 Fenretinide 58 MAXY G# 58 dyskinesia PD LID 58 cariprazine 58 Tarceva erlotinib 58 romidepsin 58 Tolamba 58 phase IIb 58 CINTREDEKIN BESUDOTOX 58 darapladib 58 Pivotal Trial 58 pentostatin 58 TELCYTA 58 Lauriad R 58 TREDAPTIVE 58 AZILECT R 58 daptomycin 58 immune modulator 58 PF # [001] 58 Prodarsan R 58 Stimuvax 58 orally administered inhibitor 58 INTEGRILIN R 58 Onco TCS 58 FASLODEX 58 Hsp# inhibitor 58 dexpramipexole 58 CTA# Injection 58 GALNS 58 ruboxistaurin 58 anti EGFR antibody 58 interferon alpha 58 antigen sparing 58 pioglitazone HCl 58 Abatacept 58 Immunotherapeutic 58 administered subcutaneously 58 EFAPROXYN 58 Tarvacin TM 58 Clevudine 58 non nucleoside HCV 58 Apoptone 58 BrachySil TM 58 Intravenous CP 58 Pivotal Phase 58 Syncria 58 UPLYSO 58 ACOMPLIA R 58 sJIA 58 macrolide antibiotics 58 MEK inhibitors 58 Onalta 58 factor Xa inhibitor 58 gastrointestinal stromal tumors GIST 58 Pralatrexate 58 protease inhibitor PI 58 Pemetrexed 58 sargramostim 58 Ofatumumab 58 Mitoxantrone 58 CGEN # 58 Azilect ® 58 Sapacitabine 58 Pharmacokinetics PK 58 leading oral taxane 58 Aurexis 58 Evoltra 58 selective inhibition 58 Pertuzumab 58 Certolizumab 58 oral iron chelator 58 Gefitinib 58 Everolimus 58 NEUGENE 58 class mGluR5 inhibitor 58 Interferon alfa 58 COREG CR 58 OXi# 58 Panzem 58 enzastaurin 58 mild vasodilator 58 Iluvien ® 58 RSD# oral 58 desvenlafaxine 58 Phase 2a trial 58 mu opioid receptor antagonist 58 Zenpep 58 non nucleoside inhibitor 58 viral kinetics 58 Trastuzumab 58 potent topoisomerase II 58 Debio 58 postsurgical pain 58 FTY# 58 acute peripheral arterial 58 acting inhaled anticholinergic 58 MDV# 58 ara C 58 Phase Ib II 58 inhaled corticosteroid ICS 58 ORENCIA ® 58 Enkephalin 58 oral taxane 58 chemotherapeutic drug 58 AV HALT 58 haematological malignancies 58 Saforis 58 selective androgen receptor modulators 58 erlotinib Tarceva R 58 INCB# [003] 58 hormone LHRH antagonist 58 NS#/#A protease 58 idiopathic pulmonary fibrosis IPF 58 radezolid 58 topical formulation 58 ARCOXIA 58 fluticasone furoate

Back to home page